BSE - Free Realtime Quote INR
Alkem Laboratories Limited (ALKEM.BO)
5,021.90
-197.80
(-3.79%)
As of 2:40:20 PM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
125,282,500
124,392,400
114,403,500
105,120,300
87,284,000
Cost of Revenue
46,865,700
50,317,700
49,823,200
42,832,900
35,863,300
Gross Profit
78,416,800
74,074,700
64,580,300
62,287,400
51,420,700
Operating Expense
56,082,700
54,226,100
51,238,600
44,595,700
34,706,500
Operating Income
22,334,100
19,848,600
13,341,700
17,691,700
16,714,200
Net Non Operating Interest Income Expense
1,556,300
1,633,600
637,800
703,100
312,000
Pretax Income
24,980,300
20,231,300
13,047,700
18,442,800
18,421,000
Tax Provision
3,005,600
2,116,700
2,979,600
1,639,600
2,243,300
Net Income Common Stockholders
21,531,800
17,957,700
9,841,700
16,456,200
15,850,200
Diluted NI Available to Com Stockholders
21,531,800
17,957,700
9,841,700
16,456,200
15,850,200
Basic EPS
180.09
150.19
82.31
137.63
132.57
Diluted EPS
180.09
150.19
82.31
137.63
132.57
Basic Average Shares
119,560.75
119,565
119,565
119,565
119,565
Diluted Average Shares
119,560.75
119,565
119,565
119,565
119,565
Rent Expense Supplemental
--
96,000
97,800
64,300
40,800
Total Expenses
102,948,400
104,543,800
101,061,800
87,428,600
70,569,800
Net Income from Continuing & Discontinued Operation
21,531,800
17,957,700
9,841,700
16,456,200
15,850,200
Normalized Income
21,536,462.31
18,803,040
10,510,638
16,480,432.60
15,084,232.80
Interest Income
--
2,757,700
1,711,400
1,226,800
901,200
Interest Expense
1,034,400
957,100
937,500
408,400
488,500
Net Interest Income
1,556,300
1,633,600
637,800
703,100
312,000
EBIT
26,014,700
21,188,400
13,985,200
18,851,200
18,909,500
EBITDA
29,295,700
24,181,400
17,089,400
21,890,800
21,655,300
Reconciled Cost of Revenue
46,865,700
50,317,700
49,823,200
42,832,900
35,863,300
Reconciled Depreciation
3,281,000
2,993,000
3,104,200
3,039,600
2,745,800
Net Income from Continuing Operation Net Minority Interest
21,531,800
17,957,700
9,841,700
16,456,200
15,850,200
Total Unusual Items Excluding Goodwill
-5,300
-1,095,000
-866,500
-26,600
872,400
Total Unusual Items
-5,300
-1,095,000
-866,500
-26,600
872,400
Normalized EBITDA
29,301,000
25,276,400
17,955,900
21,917,400
20,782,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-637.69
-249,660
-197,562
-2,367.40
106,432.80
3/31/2021 - 12/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TORNTPHARM.BO Torrent Pharmaceuticals Limited
3,238.40
-2.58%
AJANTPHARM.BO Ajanta Pharma Limited
2,684.75
-3.64%
APLLTD.BO Alembic Pharmaceuticals Limited
875.00
-0.73%
SHILPAMED.BO Shilpa Medicare Limited
680.25
-5.84%
GLAND.BO Gland Pharma Limited
1,445.50
-1.36%
CIPLA.BO Cipla Limited
1,525.80
-1.64%
AUROPHARMA.BO Aurobindo Pharma Limited
1,222.50
-2.79%
ASTRAZEN.NS AstraZeneca Pharma India Limited
8,710.00
-2.87%
PPLPHARMA.NS Piramal Pharma Limited
217.24
-1.20%
LAURUSLABS.BO Laurus Labs Limited
628.40
-2.90%